# smartbax

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smartbax

- Industry: Biotechnology
- Headquarters: Munich, Germany
- Website: www.smartbax.de
- Total disclosed funding: $6.8M
- Latest round: Seed (Aug 18, 2025)
- Investors on record: 5

## About

Founded in 2021, and based in Germany, smartbax GmbH dba smartbax, is a biotech company that targets multiple unexplored areas to effectively treat bacterial infections. The company focuses on the development of a next-generation of antibiotics in response to the growing prevalence of multidrug-resistant bacteria and targets drug-resistant pathogens like methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. This approach empowers patients to combat multiple drug-resistant bacteria effectively. Additionally, the company aims to bolster its scientific team to advance the development of its research platforms.

## Funding rounds

- Seed, Aug 18, 2025, $5.5M — Boehringer Ingelheim Venture, High-Tech Gruenderfonds, Bayern Kapital, Unternehmertum Venture Capital, Anobis Asset GmbH
- Seed, Dec 12, 2022, $1.3M — Boehringer Ingelheim Venture, High-Tech Gruenderfonds

## Investors

- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed
- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Seed
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Seed
- Unternehmertum Venture Capital (https://capitalatlas.ai/funds/unternehmertum-venture-capital) — Seed
- Anobis Asset GmbH — Seed